PNC Financial Services Group’s Greenwich LifeSciences GLSI Stock Holding History

PNC Financial Services Group’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.32K	Buy	73 +68	+1,360%	+$1.13K	﹤0.01%	4940
2026 Q2	$117	Sell	5 -5	-50%	-$122	﹤0.01%	5135
2026 Q1	$240	Sell	10 -7	-41%	-$183	﹤0.01%	5017
2025 Q4	$357	Sell	17 -12	-41%	-$126	﹤0.01%	4909
2025 Q3	$289	Buy	+29	New	+$327	﹤0.01%	4896
2021 Q3	–	Sell	-100	Closed	-$4K	–	4338
2021 Q2	$4K	Buy	+100	New	+$3.78K	﹤0.01%	3925

Other funds holding GLSI

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13B AUM 35.88% 1-Year Est. Return

PNC Financial Services Group's GLSI Position: Q3 2026 in Review

PNC Financial Services Group increased its Greenwich LifeSciences (GLSI) stake by 1,360% in Q3 2026, buying an estimated $1.13K and bringing the position to 73 shares worth $1.32K. The position accounts for ﹤0.01% of the portfolio, ranked #4940.

PNC Financial Services Group first reported a position in GLSI in Q2 2021 and has held it in 6 quarters since. The position peaked at $4K in Q2 2021. 25 funds tracked by Wall St. Rank hold GLSI as of Q3 2026.

PNC Financial Services Group held 73 shares of Greenwich LifeSciences worth $1.32K as of Q3 2026.
PNC Financial Services Group bought 68 Greenwich LifeSciences shares in Q3 2026, an estimated $1.13K.
Greenwich LifeSciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4940 holding.
PNC Financial Services Group first reported a position in Greenwich LifeSciences in Q2 2021 and has held it in 6 quarters since.
PNC Financial Services Group's Greenwich LifeSciences position peaked at $4K in Q2 2021.
25 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.